COMMUNIQUÉS West-GlobeNewswire

Galectin Therapeutics Reports Alternate Price of Common Stock in Rights Offering
23/05/2019
NORCROSS, Ga., May 23, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported the Alternate Price (i.e., the final [...]
UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction
23/05/2019
MediPharm Labs enters major U.S. led opioid clinical research trial to develop IP and exclusively manufacture CBD gelcaps TORONTO, May 23, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: [...]
Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer
23/05/2019
LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from [...]
Immuron Announces Proposed Public Offering of ADSs
23/05/2019
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the [...]
Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business
23/05/2019
Company will explore strategic alternatives for its immuno-oncology programs Company will align its resources to focus on HEPLISAV-B commercialization Eddie Gray, CEO, to retire BERKELEY, Calif., May 23, 2019 (GLOBE [...]
WW Announces Participation in Upcoming Investor Conferences
23/05/2019
NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WW), a global wellness company and the world’s leading commercial weight management program, today announced that Nick Hotchkin, [...]
Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference
23/05/2019
MALVERN, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
The Cooper Companies to Participate in the Raymond James Life Sciences and MedTech Conference
23/05/2019
PLEASANTON, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Raymond James Life Sciences and MedTech Conference in New York, NY, on June 18, 2019. Albert G. White [...]
Ziopharm Oncology Presentation at the Jefferies 2019 Global Healthcare Conference to be Webcast
23/05/2019
BOSTON, May 23, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced that Laurence Cooper, M.D., [...]
AIT Therapeutics Participating at the Oppenheimer MedTech Day on May 29
23/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®
23/05/2019
Study reviews 100 cases demonstrating 99% pedicle screw placement success rate AUDUBON, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company today announced the [...]
Equillium to Present at Jefferies 2019 Healthcare Conference
23/05/2019
LA JOLLA, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and [...]
Genfit: GENFIT Launches a Combination Therapy Clinical Program in NASH
23/05/2019
GENFIT Launches a Combination Therapy Clinical Program in NASH GENFIT has identified multiple therapeutic compounds synergistic with its lead asset, elafibranor (PPAR alpha/delta), for the treatment of NASH Combined [...]
Genfit : GENFIT lance un programme clinique de combinaisons thérapeutiques dans la NASH
23/05/2019
GENFIT lance un programme clinique de combinaisons thérapeutiques dans la NASH GENFIT a identifié plusieurs composés thérapeutiques présentant une activité synergique avec son composé phare, elafibranor (PPAR alpha/ [...]
GenMark Diagnostics to Participate in Upcoming Investor Conferences
23/05/2019
CARLSBAD, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to [...]
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in June
23/05/2019
NESS ZIONA, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Integra LifeSciences to participate in the Jefferies Healthcare Conference and the Raymond James Life Sciences and MedTech Conference in June 2019
23/05/2019
PLAINSBORO, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in June: On [...]
Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class
23/05/2019
Late-Breaking Trial Session at EuroPCR Featured Positive Data on Helix System PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [OTC: BCDA], a leader in the development of comprehensive [...]
Annual General Meeting of Active Biotech AB
23/05/2019
PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 23, 2019. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The members of the Board and the [...]

Pages